OverviewChartNewsTraderScreen

L&S Knock-Out ZEG/  DE000LX0KVK1  /

Lang & Schwarz
2024-05-18  1:03:51 PM Chg.0.00 Bid1:03:51 PM Ask1:03:51 PM Underlying Strike price Expiration date Option type
4.79EUR 0.00% 4.79
Bid Size: -		 4.89
Ask Size: -		 ASTRAZENECA PLC D... 94.2306 - 2078-12-31 Call
GlobeNewswire 05-08 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 05-06 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 05-06 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 05-02 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire 04-29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-26 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire 02-22 Gracell Biotechnologies Acquisition Completed
GlobeNewswire 02-22 Sodexo and AstraZeneca extend their global partnership for a further 5 years.
GlobeNewswire 02-20 Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
TeleTrader 02-09 Europe mostly lower premarket amid German CPI, earnings
TeleTrader 02-08 Europe closes mostly higher following earnings
TeleTrader 02-08 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 02-08 AstraZeneca's revenue in Q4 rises 5% to $11.3B
GlobeNewswire 02-05 Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire 02-02 BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...
GlobeNewswire 01-10 Absci Appoints Professor Sir Mene Pangalos to its Board of Directors